Single-cell transcriptomic analysis uncovers intratumoral heterogeneity and drug-tolerant persister in ALK-rearranged lung adenocarcinoma

被引：2
|
作者：
Kwok, Hoi-Hin [1 ]
Li, Huiyu [2 ]
Yang, Jiashuang [1 ]
Deng, Junyang [1 ]
Lee, Nerissa Chui-Mei [1 ]
Au, Timmy Wing-Kuk [3 ]
Sit, Alva Ko-Yung [3 ]
Hsin, Michael Kuan-Yew [3 ]
Ma, Stephanie Kwai-Yee [4 ]
Cheung, Lydia Wai-Ting [4 ]
Girard, Luc [2 ]
Fujimoto, Junya [5 ]
Wistuba, Ignacio Ivan [5 ]
Gao, Boning [2 ]
Minna, John Dorrance [2 ]
Lam, David Chi-Leung [1 ,6 ]
机构：
[1] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Peoples R China
[2] Univ Texas Southwestern Med Ctr, Nancy B & Jake L Hamon Ctr Therapeut Oncol Res, Dallas, TX USA
[3] Queen Mary Hosp, Cardiothorac Surg Dept, Hong Kong, Peoples R China
[4] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China
[5] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Div Pathol Lab Med, Houston, TX USA
[6] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong 999077, Peoples R China
来源：
CANCER COMMUNICATIONS | 2023年 / 43卷 / 08期
基金：
中国国家自然科学基金;
关键词：
MIGRATION; GENE;
D O I：
10.1002/cac2.12449
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：951 / 955
页数：5
相关论文
共 50 条
  • [41] Paper Single-cell transcriptomic analysis uncovers diverse and dynamic senescent cell populations
    Wechter, Noah
    Rossi, Martina
    Anerillas, Carlos
    Tsitsipatis, Dimitrios
    Piao, Yulan
    Fan, Jinshui
    Martindale, Jennifer L.
    De, Supriyo
    Mazan-Mamczarz, Krystyna
    Gorospe, Myriam
    [J]. AGING-US, 2023, 15 (08): : 2824 - 2851
  • [42] Design of a large-scale femtoliter droplet array for single-cell analysis of drug-tolerant and drug-resistant bacteria
    Iino, Ryota
    Matsumoto, Yoshimi
    Nishino, Kunihiko
    Yamaguchi, Akihito
    Noji, Hiroyuki
    [J]. FRONTIERS IN MICROBIOLOGY, 2013, 4
  • [43] Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single-cell transcriptomic analysis: Implications for distinct immunotherapy outcomes
    Fang, Xinyun
    Li, Dianke
    Wan, Shiyue
    Hu, Junjie
    Zhang, Peng
    Jie, Dai
    Chen, Linsong
    Jiang, Gening
    Song, Nan
    [J]. JOURNAL OF GENE MEDICINE, 2024, 26 (06):
  • [44] Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung Cancer
    Pailler, Emma
    Faugeroux, Vincent
    Oulhen, Marianne
    Mezquita, Laura
    Laporte, Melanie
    Honore, Aurelie
    Lecluse, Yann
    Queffelec, Pauline
    NgoCamus, Maud
    Nicotra, Claudio
    Remon, Jordi
    Lacroix, Ludovic
    Planchard, David
    Friboulet, Luc
    Besse, Benjamin
    Farace, Francoise
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (22) : 6671 - 6682
  • [45] ALK-rearranged CD30-positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large-cell lymphoma
    George, Giby, V
    Wallace, Danielle S.
    Wang, Ying
    Carney, John
    Elsadawi, Murad
    Burack, W. Richard
    Evans, Andrew G.
    Barr, Paul M.
    Velez, Moises J.
    El Hussein, Siba
    [J]. HISTOPATHOLOGY, 2024, 84 (05) : 900 - 902
  • [46] Single-cell transcriptomic analysis reveals circadian rhythm disruption associated with poor prognosis and drug-resistance in lung adenocarcinoma
    He, Lei
    Fan, Yixian
    Zhang, Yue
    Tu, Tongtao
    Zhang, Quan
    Yuan, Fahu
    Cheng, Chao
    [J]. JOURNAL OF PINEAL RESEARCH, 2022, 73 (01)
  • [47] Investigating lung adenocarcinoma tumor heterogeneity with single-cell mass cytometry
    Senosain-Ortega, Maria-Fernanda
    Zou, Yong
    Doxie, Deon B.
    Roe, Caroline E.
    Lehman, Jonathan M.
    Irish, Jonathan M.
    Massion, Pierre P.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [48] Efficacy and Safety of ALK Inhibitors in ALK-Rearranged Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Breadner, D.
    Shanmuganatjan, S.
    Boldt, G.
    Blanchette, P.
    Raphael, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1034 - S1034
  • [49] Efficacy and safety of ALK inhibitors in ALK-rearranged non-small cell lung cancer: A systematic review and meta-analysis
    Breadner, Daniel
    Blanchette, Phillip
    Shanmuganathan, Sumugan
    Boldt, Ronald Gabriel
    Raphael, Jacques
    [J]. LUNG CANCER, 2020, 144 : 57 - 63
  • [50] Efficacy of ALK Inhibitors in the Treatment of ALK-rearranged Non-small Cell Lung Cancer and Brain Metastases: A Meta-analysis
    Luo, P.
    Fan, J.
    Zou, Z.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2373 - S2373
12345